High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma

International Journal of Cancer

Volumn 97, Issue 4, 2002, Pages 432-438

  Nikkola, Johanna ^a,d   Vihinen, Pia ^a,d   Vlaykova, Tatyana ^a   Hahka Kemppinen, Marjo ^b   Kähäri, Veli Matti ^c   Pyrhönen, Seppo ^a,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Disease free survival; Melanin; Metastatic melanoma; MMP 1; MMP 13; MMP 3

Indexed keywords

COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MELANIN; STROMELYSIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REFERENCE VALUE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL RESPONSE MODIFIERS; BLEOMYCIN; CELL DIVISION; COLLAGENASES; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; ENZYME INDUCTION; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON-ALPHA; INTERLEUKIN-2; LOMUSTINE; MALE; MATRIX METALLOPROTEINASE 3; MELANINS; MELANOCYTES; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TUMOR STEM CELLS; VINCRISTINE;

EID: 0036466860     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1636     Document Type: Article

References (62)

1. Matrix metalloproteinases and their inhibitors in tumor growth and invasion
2. Matrix metalloproteinases in tumor invasion
3. Matrix metalloproteinases: A review
4. Tumor cell interactions with the extracellular matrix during invasion and metastasis
5. The role of stromelysin-1 in stromal-epithelial interactions and cancer
6. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers
7. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
8. Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer
9. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer
10. Expression of the MMP-1 in human pancreatic carcinoma: Relationship with prognostic factor
11. Expression of MMPs, MT-MMP and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis
12. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study
13. Significance of coexpression of urokinase-type plasminogen activator and matrix metalloproteinase 3 (Stromelysin) and 9 (Gelatinase B) in colorectal carcinoma
14. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas
15. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
16. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells and osteoblasts during human fetal bone development
17. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis
18. Transforming growth factorbeta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase
19. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
20. Distinct expression profiles of sromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12) and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations
21. Collagenase-3 (matrix metalloproteinase-3) expression is induced in oral mucosal epithelium during chronic inflammation
22. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
23. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
24. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas
25. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor
26. Human collagenase-3 is expressed in malignant squamous epithelium of the skin
27. Expression of collagenase-3 (matrix metalloproteinase- 13) in transitional cell carcinoma of the urinary bladder
28. S100B protein, 5-scysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma
29. Matrix metalloproteinase-2 (72 Kd type IV collagenase) expression occurs in the early stage of human melanocytic tumor progression and may have prognostic value
30. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas
31. Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
32. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein-a new prognostic marker in uveal melanoma?
33. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin
34. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MTI-MMP) correlate with melanoma progression
35. Effect if tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
36. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
37. Antimetastatic and antitumor effect of a recombinant human tissue inhibitor of metalloproteinases-2 in murine melanoma models
38. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma
39. Response of subcutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy
40. Vascularity and prognosis of metastatic melanoma
41. Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade
42. Changing views of the role of matrix metalloproteinases in metastases
43. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
44. Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer
45. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer
46. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage nonsmall cell lung cancer
47. Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma
48. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with Stage I non-small cell lung carcinoma
49. Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma
50. High collagenase-1 expression correlates to favorable chemoimmunotherapy response in human metastatic melanoma
51. Clinical potential of matrix metalloprotease inhibitors in cancer therapy
52. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells
53. Regressing thin cutaneous malignant melanomas (≤ 1.0 mm) are associated with angiogenesis
54. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
55. Serological markers for melanoma
56. Current biological markers of cutaneous melanoma progression
57. Melanin accumulation accelerates melanocyte, senescence by a mechanism involving p 161NK4a/CDK4/pRB and E2F1
58. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells
59. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways
60. Organization and regulation of mitogenactivated protein kinase signaling pathways
61. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation
62. Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the Go α chain